- Release Date: 11/06/25 09:17
- Summary: SRC Approves Dose Escalation in ADOA Clinical Trial
- Price Sensitive: Yes
- Download Document 377.2KB
- Forums
- ASX - By Stock
- PYC
- Ann: SRC Approves Dose Escalation in ADOA Clinical Trial
PYC
pyc therapeutics limited
Add to My Watchlist
0.82%
!
$1.21

Ann: SRC Approves Dose Escalation in ADOA Clinical Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.21 |
Change
-0.010(0.82%) |
Mkt cap ! $688.2M |
Open | High | Low | Value | Volume |
$1.21 | $1.21 | $1.17 | $131.8K | 110.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21711 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 639 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 703 | 1.190 |
2 | 15674 | 1.185 |
2 | 98663 | 1.180 |
1 | 80 | 1.175 |
4 | 2034 | 1.170 |
Price($) | Vol. | No. |
---|---|---|
1.195 | 1138 | 3 |
1.200 | 1586 | 2 |
1.205 | 469 | 2 |
1.210 | 631 | 1 |
1.220 | 631 | 1 |
Last trade - 13.23pm 11/09/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
EVR
EV RESOURCES LTD
Shane Menere, Non-Executive Chairman
Shane Menere
Non-Executive Chairman
SPONSORED BY The Market Online